FDA Enforcement News

Week of November 11th 2018 | FDA Sent These Warning Letters to Pharma/Device Companies

This week the FDA posted 4 new warning letters. One was issued to a cell/tissue product manufacturer, 1 to a firm for failure to list, 1 to a compounding pharmacy, and 1 to a device manufacturer. We cover 3 of these in this post.